PerkinElmer Aktie

109,39USD -0,16USD -0,15%
PerkinElmer für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 850943 / ISIN: US7140461093
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,61
T. Rowe Price Investment Management, Inc. 13,80
T. Rowe Price Investment Management, Inc. 12,68
The Vanguard Group, Inc. 11,49
Vanguard Group, Inc. (Subfiler) 10,99
Select Equity Group LP 9,14
T Rowe Price Capital Appreciation Fund 8,83
Select Equity Group LP 6,54
Capital Research & Management Co. (Global Investors) 6,22
Janus Henderson Investors US LLC 4,28
State Street Corp. 4,21
Janus Henderson Enterprise Fund 3,21
Vanguard Total Stock Market ETF 3,14
Capital Research & Management Co. (Global Investors) 3,01
BlackRock Fund Advisors 2,81

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 13 000 14 000 16 700 16 700 11 500
Umsatz pro Mitarbeiter in Mio. EUR 0,22 0,27 0,30 0,20 0,24

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 1 374 2 239 2 441 3 289 3 001
Summe Anlagevermögen 5 071 5 955 12 351 11 978 11 938
Summe Aktiva 6 539 7 960 15 001 14 130 13 565

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 2 257 2 219 5 210 4 595 4 065
Summe Fremdkapital 3 725 4 225 7 859 6 747 5 692
Summe Eigenkapital 2 814 3 735 7 141 7 383 7 873
Summe Passiva 6 539 7 960 15 001 14 130 13 565

Adresse

940 Winter Street, 02451 Waltham
Telefon +1 (781) 663-6900
Internet http://www.revvity.com

Management

Alexis Platon Michas
Non-Executive Chairman
Anita Gonzales
Vice President & Controller
Arvind Sundar Rajan
Vice President-Digital & Technology
Bryan A. Kipp
VP & General Manager-Life Sciences Integration
Daniel R. Tereau
Senior VP-Strategy & Business Development
Franklin R. Witney
Independent Director
Jayashree Kailas Thacker
Chief Information Officer & Senior Vice President
Joel S. Goldberg
Secretary, SVP-Administration & General Counsel
Madhuri Hegde
Chief Scientific Officer & Senior Vice President
Magali Four
Chief People & Culture Officer & SVP
Maxwell Krakowiak
Chief Financial Officer & Senior Vice President
Michael Klobuchar
Independent Director
Michel Pericles Vounatsos
Independent Director
Michelle McMurry-Heath
Independent Director
Miriame Victor
Chief Commercial Officer & Senior Vice President
Pascale Witz
Independent Director
Peter Barrett
Independent Director
Prahlad Ramadhar Singh
President, Chief Executive Officer & Director
Samuel Ross Chapin
Independent Director
Sophie V. Vandebroek
Independent Director
Steve Willoughby
Vice President-Investor Relations
Tajinder S. Vohra
Senior Vice President-Global Operations
Yi Ping Lin
Chief Quality, Regulatory & Clinical Officer